independent risk factor for SDB in diabetic subjects. In particular, many Japanese subjects with diabetes are less obese despite the similar prevalence of SDB compared with Caucasian [7] . It is possible that the etiology of SDB in nonobese subjects may be different from that in obese subjects.
In previous studies, a relationship between SDB and diabetic autonomic neuropathy has been suggested. For example, Ficker et al. found OSA in 26% of diabetic patients with diabetic autonomic neuropathy [1] . Cardiac autonomic neuropathy (CAN) is commonly observed early in diabetic patients, but most patients are asymptomatic. However, it remains to be elucidated whether CAN is an independent risk factor for SDB in diabetic subjects.
A standard technique to diagnose SDB is polysomnography. The methods using only overnight pulse oximetry cannot evaluate true apnea and hypopnea events. Pulse oximetry has been proposed as a simple pearance of bilateral ankle reflex; decreased vibratory sensation on bilateral medial malleoli evaluated by C 128 Hz tuning fork; bilateral symptoms such as numbness, pain, dysesthesia, paresthesia, and allodynia in feet. This study was performed in accordance with the Declaration of Helsinki and with the approval of an institutional review board.
Assessment of SDB
Overnight pulse oximetry has been proposed as a simple alternative screening method to polysomnography in the diagnosis of SDB. Nocturnal oximetry was performed over one night using a pulse oximeter (Pulsox-300i, Minolta Co., Ltd., Osaka, Japan) placed on the subject's finger with a flexible probe. The 4% ODI was selected as an index of oxygen desaturation, representing the number of events per hour of recording time in which blood oxygen fell by >4%. The 4% ODI with this device was reported to correlate strongly with the apnea-hypopnea index times/hour, and when an ODI of 5 times/hour approximately corresponded to an apnea-hypopnea index of 15 times/hour [10] . The American Academy of Sleep Medicine advocates that an apnea-hypopnea index of 15 times/hour be diagnosed as sleep apnea syndrome [11] . In this study, we diagnosed 4% ODI of more than 5 times/hour as SDB. Data were analyzed using software supplied with the equipment (DS-5, Minolta Co., Ltd., Osaka, Japan).
Heart rate variability analysis
After at least 15 minutes rest, the electrocardiogram was recorded in the supine position, and 100 consecutive R-R intervals were analyzed. The mean value of an R-R interval and the standard deviation (SDRR) were analyzed, and the coefficients of variation of R-R intervals (CVRR = SDRR/ mean R-R x100) have been calculated for the same periods.
Statistical analysis
Differences in variables between diabetes and control subjects were examined for statistical significance using the t test. Results are expressed as the mean ± SD. The relationship between SDB and various factors was investigated using multiple logistic analyses. Odds ratios with 95% confidence intervals were calculated. Statistical analysis was performed using SPSS 11.0J (SPSS Inc., Chicago, IL) on a personal computer. Statistical significance was determined as P < 0.05. screening method to polysomnography in the diagnosis of SDB. In the present study, we examined the relationship between SDB by nocturnal pulse oximetry and coefficient of variation of R-R intervals (CVRR), which is the standard analysis widely used to non-invasively evaluate cardiac autonomic functions, in Japanese subjects with type 2 diabetes.
Materials and Methods

Patients
The subjects of this study were enrolled from the 40 to 79 year-old patients who were consecutively admitted in our hospital for the purpose of diabetes education from 2007 to 2009. Diagnosis of type 2 diabetes was made on the absence of anti-glutamic acid decarboxylase antibody, medical history, physical examination, current medication, family history, laboratory data, and the absence of other secondary cause of diabetes. A total of 369 Japanese patients with type 2 diabetes agreed to participate in this study and all of them were measured the value of oxygen desaturation per hour (oxygen desaturation index, ODI) as an indicator of SDB by nocturnal pulse oximetry. Subjects with a history of stroke and chronic heart failure, atrial fibrillation, hypothyroidism, severe pulmonary and cardiac disease were excluded. The remaining 261 Japanese patients with type 2 diabetes (161 men and 100 women, mean ± SD age, 62.8 ± 9.9 years) were classified under two groups of nonobese (BMI<25 kg/ m 2 ) and obese (BMI ≥ 25 kg/m 2 ), which were defined according to the criteria by the Japanese Society for the Study of Obesity [8] . Non-diabetes subjects, who visited the health care check-up center of our institute, included 63 Japanese without type 2 diabetes (44 men and 19 women, mean ± SD age, 63.4 ± 10.8 years). As risk factors for SDB, we analyzed age, sex, BMI, systolic blood pressure (SBP), diastolic blood pressure (DBP), heart rate (HR), neck circumference, glycated hemoglobin (HbA1c), CVRR and the presence of diabetic neuropathy. HbA1c was assayed by a high-solution high-performance liquid chromatography. The value of HbA1c, which is equivalent to the internationally used HbA1c (%) (HbA1c [NGSP]) defined by the NGSP (National Glycohemoglobin Standardization Program), is expressed by adding 0.4% to the HbA1c (JDS) (%) defined by the Japan Diabetes Society (JDS) [9] . Diabetic polyneuropathy was diagnosed when two of three following findings existed: decrease or disap-ysis to the data as subgroup analysis. We analyzed risk factors for SDB in two groups with type 2 diabetes; nonobese group (BMI <25 kg/m 2 ) and obese group (BMI ≥25 kg/m 2 ). In the nonobese group with type 2 diabetes, the prevalence of SDB was 16.3% (Table  1) , it tends to be higher than that (6.7%) in nonobese Japanese subjects without type 2 diabetes (Table 1) , and the diabetes subjects with SDB had lower CVRR than those without SDB (Table 3) . Meanwhile, in the obese group with type 2 diabetes, the prevalence of SDB was 34.2% (Table 1) , it was slightly higher than that (27.8%) in obese Japanese subjects without type 2 diabetes (Table 1) , and the diabetes subjects with SDB had higher HR than those without SDB (Table 3) . Furthermore, multiple regression analysis revealed that CVRR was a significant factor for SDB in nonobese subjects with type 2 diabetes, while SBP and HR were significant factors for SDB in obese subjects with type 2 diabetes (Table 3) .
results
The characteristics of the subjects are presented in Table 1 . The patients who were diagnosed to have SDB (4% ODI ≥5 per hour) were 24.5% of total subjects with type 2 diabetes. It was significantly higher than that (12.7%) in non-diabetic Japanese subjects (P <0.05). By univariate analysis, the diabetic subjects with SDB had higher BMI, HR and neck circumference than the diabetic subjects without SDB ( Table 2 ). In contrast, age, sex, SBP, DBP, duration of diabetes, HbA1c, CVRR and the frequency of diabetic neuropathy had no significant difference between the subjects with SDB and without it ( Table 2 ). In addition, multiple regression analysis revealed that BMI and HR were significant factors for SDB in subjects with type 2 diabetes (Table 2) .
Because BMI is considered to be associated strongly than other risk factors for SDB, we restricted our anal- Data are presented as mean±S.D. or n (%). *P <0.05, **P <0.01 Data are presented as mean±S.D. or n (%). *P <0.05, **P <0.01
The odds ratios (ORs) and 95% confidence intervals (CIs) for SDB were calculated by multiple logistic regression analysis. *P <0.05 Table 3 The clinical characteristics of the subjects and association between SDB and various risk factors on multiple logistic regression analysis for the nonobese and obese subjects with type 2 diabetes The odds ratios (ORs) and 95% confidence intervals (CIs) for SDB were calculated by multiple logistic regression analysis. *P <0.05
should be screened for SDB. There are several limitations in the present study. First, we used pulse oximetry to establish the diagnosis of SDB, and not polysomnography, although the formal diagnosis of sleep apnea required polysomnographic studies. Since a full polysomnography was not performed, we were unable to differentiate between obstructive and central events and to assess the influence on sleep architecture. Nocturnal hypoxia caused by other causes such as pulmonary disease or cardiac disease cannot be excluded. Furthermore, the definition of 4% ODI ≥ 5 per hour in the present study might have overestimated respiratory disturbance events during sleep. Moreover, in the present study, there might be a selection bias admittedly for severely affected patients because they were the ones who required hospital admission in one institute.
Despite of the limitations above, this preliminary study suggest common pathogentic mechanisms of CAN and SDB in subjects with type 2 diabetes. It is plausible that diabetic chronic autonomic peripheral neuropathy may cause CAN and SDB through an increase in sympathetic activity and decrease in vagal activity, as suggested in a community-based study [15] . Further studies are required to establish a relationship between other measures of autonomic neuropathy (e.g. sweat testing, skin nerve biopsy, orthostatic response of blood pressure, gastric emptying) and SDB in subjects with type 2 diabetes.
In conclusion, SDB is frequent in Japanese subjects with type 2 diabetes, including nonobese ones, whom CAN may be associated with SDB. The presence of SDB should be kept in mind in type 2 diabetic patients with abnormality in CVRR variation in electrocardiogram even though they are not obese.
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Discussion
It was reported that the prevalence of OSA in Caucasians was up to 23% [12] or 58% [13] in patients who were known to have diabetes. Another study showed that 34% of type 2 diabetic patients with poor diabetic control had OSA, which was related to abdominal obesity [3] . The prevalence of SBD was reported to be higher in a diabetic male population in comparison with a non-diabetic male population in Japanese subjects [7] . Although it is plausible that the prevalence of SDB with type 2 diabetes may vary with the variability due to the differences in definitions of SDB used and measurement parameters, the present result of frequency of SDB in type 2 diabetes (24.5%) seems to be consistent with those in these previous studies.
Obesity is a well-established risk factor for SDB. Possible mechanisms of SDB in obesity include the upper airway narrowing and increasing collapsibility due to fat accumulation in the pharynx and the neck [8] . The present study also indicated that, BMI was a significant factor for SDB in subjects with type 2 diabetes as a whole. However, the prevalence of SDB in nonobese subjects with type 2 diabetes was unexpectedly high (16.3%), prompting us to investigate other factors than BMI related to SDB in Japanese diabetic subjects.
We found that CVRR was an independent factor related to SDB in nonobese subjects with type 2 diabetes. CAN is often present in subjects with diabetic autonomic neuropathy, which may be often associated with ventilator dysfunction [1] . CAN is associated with increased mortality or adverse cardiac events. A high increase of sudden deaths has been reported in patients with diabetic autonomic neuropathy especially when they are sleep [14] . Taken together, since both diabetic autonomic neuropathy and SDB may possibly contribute to the increased cardiovascular disease and sudden deaths in subjects with diabetes and SDB, the patients with diabetes, even if they are nonobese, references
